AnGes MG Inc.

01/10/2020 | Press release | Distributed by Public on 01/09/2020 23:26

Notice of Additional Equity Investment in Emendo Biotherapeutics, Owner of Advanced Technology in Genome Editing, and Decision on Change of Status to Affiliated Company